KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,177,600 | -17.3% | 2,980,000 | -4.0% | 0.42% | -4.9% |
| Q2 2023 | $32,850,900 | -13.5% | 3,105,000 | 0.0% | 0.45% | -20.8% |
| Q1 2023 | $37,974,150 | -1.5% | 3,105,000 | 0.0% | 0.56% | -2.3% |
| Q4 2022 | $38,533,050 | -20.0% | 3,105,000 | -11.9% | 0.58% | -35.3% |
| Q3 2022 | $48,152,000 | -45.3% | 3,525,000 | -26.6% | 0.89% | -48.8% |
| Q2 2022 | $87,984,000 | +14.0% | 4,800,000 | 0.0% | 1.74% | +23.4% |
| Q1 2022 | $77,184,000 | +37.8% | 4,800,000 | +20.0% | 1.41% | +47.8% |
| Q4 2021 | $56,000,000 | -25.3% | 4,000,000 | 0.0% | 0.95% | -19.0% |
| Q3 2021 | $74,920,000 | -13.2% | 4,000,000 | -3.4% | 1.18% | -21.6% |
| Q2 2021 | $86,319,000 | -23.7% | 4,140,000 | +3.5% | 1.50% | -23.1% |
| Q1 2021 | $113,080,000 | -13.4% | 4,000,000 | 0.0% | 1.95% | -13.2% |
| Q4 2020 | $130,640,000 | +75.1% | 4,000,000 | +64.3% | 2.25% | +112.3% |
| Q3 2020 | $74,608,000 | +335.9% | 2,435,000 | +131.9% | 1.06% | +213.6% |
| Q2 2020 | $17,115,000 | – | 1,050,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |